Oklahoma State University Center for Health Sciences
Oklahoma State University Center for Health Sciences

News Alert:

 

Education

1988-1990
Postdoctoral Research Fellow 
Department of Cell Biology and Neuroanatomy
University of Minnesota
Minneapolis, MN

1988
Ph.D. (Pharmacology)
Mayo Graduate School of Medicine
Rochester, MN

1984
M.S. (Biological Sciences)
University of Illinois
Chicago, IL

1978-1981
Science/Math Instructor
American Peace Corps in Nepal, Katmandu, Nepal

1978
B.A. (Biology)
Augustana College
Rock Island, IL

Professional Experience

2007-present
Chair, Dept. of Pharmacology/Physiology, OSU-CHS, Tulsa, OK

2000-present
Professor of Pharmacology, Dept. of Pharmacology and Physiology, Oklahoma State University College of Osteopathic Medicine (OSU-COM), Tulsa, OK

1993-2000
Associate Professor of Pharmacology, Dept. of Pharmacology and Physiology, OSU-COM

1990-1993
Assistant Professor of Pharmacology, Dept. of Pharmacology and Physiology, OSU-COM

1989-1990
Development Manager, Minnesota Academy of Science, St. Paul, MN

1984-1986
President (founding), Mayo Graduate Students Association, Mayo Graduate School of Medicine, Rochester MN

Service & Contribution

  • President, Faculty Senate, OSU-CHS, 2003-2004
  • Vice-President (President-Elect), Faculty Senate, OSU-CHS, 2001-2002
  • Founding Member & Chair (2000), Biomedical Sciences Graduate Committee, OSU-CHS, 1994-2001
  • Chair, Hazardous Materials and Equipment, OSU-CHS, 1996-2001
  • Member, Promotion and Tenure Comitteee, OSU-COM, 1994, 2000, 2001
  • Senator, Faculty Senate, 1996-1998
  • Member, Research Committee, OSU-CHS, 1991-2000
  • Member, Academic Appeals Board, OSU-CHS, 1991-1992
  • Member, Learning Resources Committee, OSU-CHS, 1991-1992
  • Chair ('90-'93), Member ('94-'99), Animal Use Committee (IACUC), OSU-CHS, 1990-1999
  • Webmaster for the International Narcotics Resarch Conference (INRC), Ongoing

Professional Societies

  • American Society for Pharmacology and Experimental Therapeutics (ASPET)
  • American Physiological Society (APS)
  • Society for Neuroscience (SFN)
  • International Narcotics Research Conference (INRC)
  • American Association for the Advancement of Science (AAAS)
  • Oklahoma Academy of Sciences (OAS)
  • Scientists Center for Animal Welfare (SCAW)
  • Oklahoma Center for Neuroscience (OCNS)

Honors & Awards

  • Young Investigator Travel Award, American Pain Society, San Diego, CA, 1992
  • NIDA Travel Award, International Narcotics Res. Comm. (INRC), Keystone, CO, 1992
  • Young Investigator Travel Award, American Pain Society, New Orleans, LA, 1991
  • Young Scientist Travel Award, ASPET Annual Meeting, San Diego, CA, 1991
  • Fulbright Scholarship for Research & Teaching in India (declined to accept faculty position), 1990
  • CPDD Travel Award, CPDD Annual Meeting, Keystone, CO, 1990

Extramural Funding

2007-2010
“Functional Evolution of Opioid Receptors,” NIH NIDA AREA Grant, R15DA12448, C.W. Stevens (PI), $150,000 (direct costs)

2004-2006
"Functional Evolution of Opioid Receptors," NIH NIDA AREA (Academic Research Enhancement Award) Grant, R15DA12448, C.W. Stevens (PI), $100,000 (total direct costs) competitive renewal

2002-2004
"Sequence and Pharmacology of Novel Opioid Receptors," Oklahoma Center for the Advancement of Science and Technology (OCAST) C.W. Stevens, (PI), $68, 264 (direct costs)

2001-2003
"Functional Evolution of Opioid Receptors," NIH NIDA AREA (Academic Research Enhancement Award) Grant, R15DA12448, C.W. Stevens (PI), $100,000 (total direct costs) competitive renewal.

1999-2001
"Functional Evolution of Opioid Receptors," NIH NIDA AREA (Academic Research Enhancement Award) Grant, R15DA12448, C.W. Stevens (PI), $69,605. (total direct costs)

1998-1999
"Testing and Comparison of Analgesic Agents," American College of Laboratory Animal Medicine (ACLAM), C.W. Stevens (PI), $11,555. (total direct costs)

1995-1997
"Graduate Student Research," Gardner Spring, Co., Tulsa, OK. ($4,000)

1994-1996
NRSA postdoctoral grant for Dr. Stan Willenbring, C.W. Stevens (sponsor).

1992-1997
"Studies of Opioid Analgesia in Amphibians," NIH NIDA First Award (DA07326), C.W. Stevens, Principal Investigator (PI), $418,000. (direct costs)

1992-1996
"Spinal Sites of Endogenous Opioid Action in Amphibians," Research Grant, Whitehall Foundation, C.W. Stevens, PI, $70, 785.

1991-1992
"Nociceptive Processing in the Amphibian Spinal Cord," Grants-In-Aid, Whitehall Foundation Research Fund, C. W. Stevens, PI, $10,375.

1988-1990
"NIDA Neuroscience Training Grant," Postdoctoral position (salary only), University of Minnesota Medical School, Minneapolis, MN.

Representative Publications & Presentations

Stevens, C.W. and Pezalla, P.D., A spinal site mediates opiate analgesia in frogs Life Sci. 33: 2097-2013, 1983.

Stevens, C.W. and Pezalla, P.D., Naloxone blocks the analgesic action of levorphanol but not dextrorphan in the leopard frog Brain Research 301: 171-174, 1984.

Pezalla, P.D., and Stevens, C.W., Behavioral effects of morphine, levorphanol, dextrorphan, and naloxone in Rana pipiensPharm. Biochem. Behavior 21: 213-217, 1984.

Yaksh, T.L., and Stevens, C.W., Simple catheter preparation permitting bolus intrathecal administration during chronic intrathecal infusion Pharmacology, Biochemistry and Behavior, 25: 483-485, 1986.

Stevens, C.W. and Yaksh, T.L., Spinal action of dermorphin an extremely potent opioid peptide from frog skin Brain Research, 385: 300-304, 1986.

Stevens, C.W. and Yaksh, T.L., Dynorphin A and related peptides administered intrathecally in the rat: A search for putative kappa opiate receptor activity J. Pharmacol. Exp. Ther., 238: 833-838, 1986.

Stevens, C.W., Pezalla, P.D., and Yaksh, T.L., Spinal antinociceptive action of three representative opioids in frogs Brain Research, 402: 201-203, 1987.

Stevens, C.W., Weinger, M.B. and Yaksh, T.L., Intrathecal dynorphins suppress hindlimb electromyographic activity in ratsEur. J. Pharmacol., 138: 299-302, 1987.

Stevens, C.W. and Yaksh, T.L., Chronic antagonist infusion does not increase morphine antinociception in rat spinal cordBrain Research, 425: 388-390, 1987.

Stevens, C.W., Monasky M.S. and Yaksh, T.L., Spinal infusion of opiate and alpha-2 agonists in rats: Tolerance and cross-tolerance studies J. Pharmacol. Exp. Ther. 244: 63-70, 1988.

Schick, R.R., Stevens, C.W., Yaksh, T.L. and Go, V.L.W., Chronic intraventricular administration of CCK octapeptide suppresses feeding in rats Brain Research, 448:294-298, 1988.

Stevens, C.W., and Yaksh, T.L., Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion J. Pharmacol. Exp. Ther. 250: 1-8, 1989.

Sosnowski, M., Stevens, C.W., and Yaksh, T.L., Assessment of the role of A1/A2 adenosine receptors mediating the purine antinociceptive, motor, and autonomic function in rat spinal cord J. Pharmacol. Exp. Ther. 250: 915-922, 1989.

Stevens, C.W., and Yaksh, T.L., Time course characteristics of tolerance development to continuously infused antinociceptive agents in rat spinal cord J. Pharmacol. Exp. Ther. 251: 216-233, 1989.

Stevens, C.W., and Yaksh, T.L., Magnitude of opioid dependence after continuous intrathecal infusion of mu and delta opioids in the rat Eur. J. Pharmacol. 166: 467-472, 1989.

Morón, M.A.,Stevens, C.W., and Yaksh, T.L., Diltiazem enhances and flunarizine inhibits nimodipine's antiseizure effectsEur. J. Pharmacol. 163: 299-307, 1989.

Stevens, C.W. and Pezalla, P.D., Opioid system down-regulation during hibernation in amphibians. Brain Research494:227-231, 1989.

Yanez, A., Sabbe, M.B., Stevens, C.W., and Yaksh, T.L., Interaction of midazolam and morphine in the rat spinal cordNeuropharmacology 29: 359-364, 1990.

Morón, M.A., Stevens, C.W., and Yaksh, T.L., The antiseizure activity of dihydropyridine calcium channel antagonists in the conscious rat J. Pharmacol. Exp. Ther. 252: 1150-1155, 1990.

Monasky, M., Zinsmeister, A., Stevens, C.W., and Yaksh, T.L., The interaction of intrathecal morphine and ST-91 on antinociception in the rat J. Pharmacol. Exp. Ther. 254: 383-392, 1990.

Stevens, C.W., Lacey, C.B., Miller, K.E., Elde, R.P., and Seybold, V.S., Biochemical characterization and regional quantification of mu, delta, and kappa opioid binding sites in rat spinal cord Brain Research 550: 77-85, 1991.

Stevens, C.W., Kajander, K.C., Bennett, G.J., and Seybold, V.S., Bilateral and differential changes in spinal mu, delta and kappa opioid binding in rats with a painful, unilateral neuropathy Pain 46: 315-326, 1991.

Stevens, C.W. and Yaksh, T.L., Studies of morphine and DADLE cross-tolerance after continuous intrathecal infusion in the rat Anesthesiology 76: 596-603, 1992.

Stevens, C.W., Alternatives to the use of mammals for pain research Life Sciences 50: 901-912, 1992.

Stevens, C.W. and Kirkendall, K., Time course and magnitude of tolerance to the analgesic effects of systemic morphine in amphibians Life Sciences 52: PL111-116, 1993.

Stevens, C.W., Alan J. Klopp, and J. Anthony Facello, Analgesic potency of mu and kappa opioids after systemic administration in amphibians J. Pharmacol. Exp. Ther. 269: 1086-1093, 1994.

Brenner, G.M., Deason, L. L, Klopp, A.J., and Stevens, C.W., Analgesic potency of alpha adrenergic agents after systemic administration in amphibians J. Pharmacol. Exp. Ther. 270: 540-545, 1994.

Stevens, C.W., Sangha S. and Ogg, B., Analgesia produced by immobilization stress and an enkephalinase-inhibitor in amphibians Pharm. Biochem. Behav. 50: 675-680, 1995.

Stevens, C.W. and Seybold, V.S., Changes of opioid binding density in the rat spinal cord following unilateral dorsal rhizotomy Brain Research 687: 53-62, 1995.

Willenbring, B. and Stevens, C.W., Thermal, mechanical, and chemical peripheral sensation in amphibians: opioid and adrenergic effects Life Sciences 58: 125-133, 1996.

Stevens, C.W. Relative analgesic potency of mudelta, and kappa opioids after spinal administration in amphibians J. Pharmacol. Exp. Ther. 276: 440-448, 1996.

Stevens, C.W. and Brenner, G.M., Spinal administration of adrenergic agents produces analgesia in amphibians Eur. J. Pharmacol., 316: 205-210, 1996.

Stevens, C.W., and Rothe, K.S., Supraspinal administration of opioids with selectivity for m -, d - and k -opioid receptors produces analgesia in amphibians European Journal of Pharmacology, 331: 15-21, 1997.

Willenbring, B. and Stevens, C.W., Spinal mu, delta, and kappa opioids alter chemical, mechanical and thermal sensitivities in amphibians Life Sciences 61: 2167-2176, 1997.

Stevens, C.W. and Newman, L.C., Spinal administration of selective opioid antagonists in amphibians: evidence for an opioid unireceptor Life Sciences-Pharmacology Letters 64: PL125-130, 1999.

Newman, L. C., Wallace D.R. and Stevens, C.W., Characterization of [3H]-diprenorphine binding in Rana pipiens: observations of filter binding enhanced by naltrexone Journal of Pharmacological and Toxicological Methods 41: 43-48, 1999.

Newman, L. C., Wallace D.R. and Stevens, C.W., Selective opioid agonist and antagonists displacement of [3H]-naloxone binding in amphibian brain European Journal of Pharmacology, 397: 255-262, 2000.

Newman, L. C., Wallace D.R. and Stevens, C.W., Selective opioid agonist and antagonists competition for [3H]-naloxone binding in amphibian spinal cord Brain Research, 884: 184-191, 2000.

Stevens, C.W., MacIver, D. N., Newman, L.C., Testing and comparison of non-opioid analgesics in amphibians Cont. Topics in Lab. Animal Sciences 40: 47-51, 2001.

Newman, L. C., Sands, S.S., Wallace D.R. and Stevens, C.W., Characterization of selective μ, κ, and δ opioid radioligand binding in amphibian brain Journal of Pharmacology and Experimental Therapeutics 301:364–370, 2002.

Stevens, C.W., Opioid research in amphibians: a unique perspective on mechanisms of opioid analgesia and the evolution of opioid receptors Reviews in Analgesia 7: 69-82, 2003.

Stevens, C.W., Opioid research in amphibians: an alternative pain model yielding insights on the evolution of opioid receptors. Brain Res Brain Res Rev. 46:204-15, 2004.

Stevens, C.W., Molecular evolution of vertebrate opioid receptor proteins: a preview. In: Recent Developments in Pain Research, 2005, pps. 13-29, Ed. Capasso, A., Research Signpost, Kerala, India, 2005.

Mohan, S. and Stevens, C.W., Systemic and spinal administration of the mu opioid, remifentanil, produces antinociception in amphibians, European Journal of Pharmacology, 534: 89-94, 2006.

Brenner, G.M. and Stevens, C.W.Pharmacology, 2/e. Pharmacology textbook for medical and health professional students, Elsevier, London, March, 2006.

Stevens, C.W., Toth G., Borsodi A., Benyhe S., Xendorphin B1, a novel opioid-like peptide determined from a Xenopus laevisbrain cDNA library, produces opioid antinociception after spinal administration in amphibians. Brain Res Bulletin., 71:628-632, 2007.

Stevens, C.W., Brasel, C.M. and Mohan, S.K., Cloning and bioinformatics of amphibian mu, delta, kappa, and nociceptin opioid receptors expressed in brain tissue: evidence for opioid receptor divergence in mammals.  Neuroscience Letters, 419: 189-194, 2007

Davis, R.L., Buck, D.J., Saffarian, N. and Stevens, C.W., The opioid antagonist, β-funaltrexamine, inhibits chemokine expression in human astroglial cells. Journal of Neuroimmuunology 186: 141-149, 2007.

Davis, R.L., Buck, D.J., Saffarian, N., Mohan, S.K., Desilva, U., Fernando, S.C., Stevens, C.W., β-funaltrexamine inhibits inducible nitric-oxide synthase expression in human astroglial cells. J. Neuroimmune Pharm. 3: 150-153, 2008.

Stevens, C.W., Non-Mammalian Models for the Study of Pain, in Sourcebook of Models for Biomedical Research, Ed. Conn, M, Humana Press, Towata, NJ, USA, pp. 341-352, 2008.

Brasel, C.M., Sawyer, G.W. and Stevens, C.W., A pharmacological comparison of the cloned frog and human mu opioid receptors reveals differences in affinity and selectivity. Eur J Pharmacol, 2008 (in press)

Stevens, C.W., Martin, K.K. and Stahlheber, B.W., Nociceptin produces antinociception after spinal administration in amphibians. Pharm Biochem Behav, 2008 (in press).

National and International Presentations 
"Opioid antinociception in amphibians," Satellite Symposium: Behavioral Biology of Nociception: Comparative, Developmental, and Sexual Aspect, Society for Neuroscience, New Orleans, LA, November, 1987.

"An amphibian model for the assessment of opioid action," Annual Meeting of the College on Problems in Drug Dependence (CPDD), Richmond, VA, June, 1989.

"Alternatives to the use of mammals for pain research," OSU College of Veterinary Sciences, Annual Research Symposium, Stillwater OK, May 1991.

"An amphibian model for pain research," Northeastern State University, Science and Technology Seminar Series, Tahlequah OK, October, 1991.

"An amphibian model for pain research," Children's Medical Center, Chapman Research Institute Seminar Series, Tulsa OK, November, 1991.

"An amphibian model for pain research," Oklahoma State University, Dept. of Zoology Seminar Series, Stillwater OK, January, 1992.

"Alternatives to the use of mammals for opioid research," OSU College of Veterinary Sciences, Annual Research Symposium, Stillwater OK, May 1992.

"An amphibian pain model for opioid research," University of Tulsa Biology Department Colloquium, Tulsa, OK, September 1992.

"An amphibian pain model for opioid research," University of Oklahoma Health Sciences Center, Dept. of Anatomy, Oklahoma City, OK, October, 1992.

"Studies of opioid tolerance in an amphibian pain model," 1st Annual Young Investigators Symposium, College on Problems in Drug Dependence (CPDD), Toronto, June, 1993.

“Relative analgesic potency of mu and kappa opioids in amphibians: a unique assay for kappa opioid action?”, College on Problems of Drug Dependence (CPDD), Palm Beach, FL, 1994.

"An amphibian pain model for opioid research," UCSD, Anesthesiology Research Lab Group, April, 1994.

“An amphibian model for pain research”, Pharmacology Dept., LSU Med Center, New Orleans, 9/27/94.

"Alternatives to the use of mammals for pain research," NIH/OPPR/LSU sponsored workshop, New Orleans, September 29-30, 1994.

“Alternatives to the use of mammals for pain research: an amphibian model”, SCAW/CCAC Conference, Toronto, Canada, September 28, 1995.

“An amphibian model for studies of opioid action”, University of Minnesota Medical School, Dept. of Pharmacology Seminar Series, Minneapolis, MN, January 19, 1996.

“An alternative model for testing of opioid analgesics and pain research using amphibians”, 2nd World Congress on Alternatives and Animal Use in the Life Sciences, Utrecht, Netherlands, October 21, 1996.

“From Pond to Pain: An Amphibian Model for Opioid Analgesia”, Anatomy/Physiology Seminar Series, University of Oklahoma Health Sciences Center, Oklahoma City, OK, May 20, 1997.

“From Pond to Pain: An Amphibian Model for Opioid Analgesia”, Annual Meeting of the Midwest Pain Interest Group (PIG), Medical College of Wisconsin, Milwaukee, WI, June 6, 1997.

“Studies of selective mu opioid antagonism after spinal administration of beta-FNA in amphibians”, College on Drug Dependence (CPDD) Annual Meeting, Nashville, TN, June 16, 1997.

“The unireceptor hypothesis of opioid antinociception in amphibians: implications for the evolution of opioid receptors”, invited symposium speaker for the International Narcotics Research Conference (INRC), Germany, July,‘98

“An Amphibian Whole-Animal Alternative for the Study of Pain”, invited participant for symposium, All Creatures Weird and Wonderful: Revolutionary Approaches to Medical Discovery, AAAS Meeting, Anaheim, CA, Jan, 23, 1999.

“Perspectives on Opioid Tolerance from Basic Research”, M.D. Anderson- University of Texas Medical Center, Dept. of Anesthesiology and Critical Care, November 18, 1999.

“An Alternative Model for Pain and Analgesia Research Using Amphibians”, Scientists Center for Animal Welfare (SCAW), Spring Meeting, Baltimore, MD, May 19, 2000.

“From Pond to Pain: Investigating Mechanisms of Opioid Analgesia Using Amphibians”, Oklahoma State University, Dept. of Zoology, Stillwater, OK, Sept. 22, 2000.

“Investigating Mechanisms of Opioid Analgesia in Amphibians”, LSU-Medical Center, Dept. of Pharmacology, Shreveport, LA, December 5, 2000.

“An Amphibian Model for the Study of Opioid Analgesics”, University of Kansas Medical Center, Dept. of Pharmacology, Toxicology and Therapeutics, Kansas City, KS, September 11, 2001. (re-scheduled and presented on December 11, 2001)

“An Amphibian Model for Analgesia Testing”, Univ. of Oklahoma Dental School, Student Research Society Annual Banquet, Myriad Convention Center, Oklahoma City, OK, April 12, 2002.

“Mechanisms of Opioid Analgesia in Amphibians”, Dept. of Neuroscience, Univ. of MN, Minneapolis, MN, April 16, 2002.

“An Amphibian Model for Investigation of Opioid Analgesia and Pain-processing”, at the Cross-Species Approach to Pain and Analgesia conference, sponsor: Mayday Fund, Airlie Conference Center, Warenton, VA, Sept. 19, 2002.

“An Amphibian Model for Opioid Research”, Dept. of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR, October 16, 2002.

“Opioid research using amphibians and the evolution of opioid receptors”, Dept. of Medicinal Chemistry, University of Mississippi, Oxford. MI, May 8, 2003.

“Opioid research using amphibians and the evolution of opioid receptors”, British Society for Experimental Biology, Symposium speaker, Edinburgh, Scotland, April 2, 2004.

“Opioid research using amphibians and the evolution of opioid receptors”, European Opioid Conference, Symposium speaker, Budapest, Hungary, April 8, 2004.

“Opioid research using amphibians: a unique perspective on the evolution of vertebrate opioid receptors”, Seminar for the Center for Pain Research, University of Minnesota, Minneapolis, MN, April 15, 2004.

“An Evolutionary Approach to Understanding Vertebrate Opioid Rceptors”, Veterinary Biomedical Sciences Seminar Series, OSU-College of Veterinary Medicine, Stillwater, OK, January 27, 2005.

“Opioid research using amphibians: An Evolutionary Approach to Understanding Vertebrate Opioid Receptors”, Seminar for the Department of Neuroscience, University of Minnesota Medical School, Minneapolis, MN, April 12, 2005. 

“Opioid analgesia research in amphibians: from behavioral assay to cloning opioid receptor genes”, Keynote speaker, Annual meeting of the Association of Reptile and Amphibian Veterinarians, Baltimore, MD, April 23-26, 2006

“Insights on the Molecular Evolution of Vertebrate Opioid Receptors: From Frog to Man", Physiology Seminar Series, University of Oklahoma Health Sciences Center, Oklahoma City, OK, January 25, 2007.

"Evolution of opioid receptors: why the mu opioid receptor would make Darwin proud" , International Narcotics Research Conference (INRC) Annual Meeting,  Charleston, SC, USA, July 15, 2008.

 

Instructional Activities

  • Medical Pharmacology - MS II
  • Neuropharmacology - Graduate


Research Interests

Dr. Stevens maintains research interests in two main areas of opioid pharmacology: 1) The evolution of opioid receptor proteins, and 2) the role of opioids in neuroimmune interactions. Brief descriptions of these research areas are given below; publications for further information are found in Dr. Stevens’ CV which is linked above.

1) The evolution of opioid receptor proteins is an avenue of research that began with the development of a non-mammalian alternative model for pain research using amphibians. After showing that opioids produce analgesia in amphibians similarly to that observed in rats, mice and humans, further studies suggested that the selectivity of opioid receptors in amphibians was different than those expressed in humans. Bioinformatic analysis alongside experimental studies confirmed novel hypotheses that the evolution of vertebrate opioid receptors is characterized by a vector of increasing selectivity and a significantly greater positive selection on the mu opioid receptor protein.

Research skills used in this area are modern molecular techniques including mRNA isolation, PCR, quantitative Real-Time PCR, site-directed mutagenesis, and bioinformatics.

2) The role of opioids in neuroimmune interactions is a newer area of research catalyzed by the collaboration with Dr. Randall Davis. Opioids are a large class of well-known agents that are comprised of both exogenous drugs and endogenous opioid peptides. The established molecular targets of opioids are the three canonical opioid G protein-coupled receptors (GPCR); mudelta and kappa. However, emerging evidence suggests that opioids exert actions through non-GPCR dependent mechanisms, which remain to be elucidated. Given the sheer numbers of people using and abusing opioids, it is essential that we know as much as possible, about as many as possible, opioid sites of action. The research projects in this area are geared towards characterizing novel opioid sites of action which modulate innate immune functions using microglia and astroglia cell cultures.

Research skills used in this research are modern cell culture and assay techniques (Western blots, co-immunoprecipitation, ELISA) and molecular techniques including mRNA isolation, PCR, and quantitative Real-Time PCR.

Graduate Student Training

Dr. Stevens is actively involved in the training of graduate students in the biomedical sciences program. Ph.D. students trained in his laboratory have gone on to faculty positions at public and private institutions and research postdoctoral positions. If interested in pursuing research in the laboratory towards a graduate degree, please contact Dr. Craig W. Stevens by the email address given above.

Biographical Information

Dr. Stevens joined the department in 1990 following a postdoctoral fellowship at the University of Minnesota Medical School, Minneapolis. He received a Ph.D. in Pharmacology from the Mayo Clinic Medical School in 1988 and a M.S. in Biological Sciences from the University of Illinois in Chicago in 1984. Before that, he served a 27-month tour-of-duty in the American Peace Corps in Nepal. He completed his undergraduate degree at Augustana College in Rock Island, IL. Dr. Stevens is a native of Chicago, growing up in the city a few miles from Wrigley Field.

Recreational Interests

Dr. Stevens is an avid juggler and co-founded the T-Town Juggling Club. The Medical School Chapter of OSU-COM chapter of the T-Town Jugglers meets every Tuesday night on occasional Wednesday nights at Founders Hall on the OSU-CHS campus.

OSU-CHS on Facebook OSU-CHS on Twitter OSU-CHS on Foursquare OSU Medicine on YouTube Google+